Annual Drug Patent Expirations for DUAKLIR+PRESSAIR
Duaklir Pressair is a drug marketed by Astrazeneca and is included in one NDA. There are four patents protecting this drug.
This drug has one hundred and twenty-seven patent family members in forty-three countries.
The generic ingredient in DUAKLIR PRESSAIR is aclidinium bromide; formoterol fumarate. Additional details are available on the aclidinium bromide; formoterol fumarate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
